Company profilePharmaceutical#287 of 1,318 in Pakistan✓ No DRAP alerts

Zanctok Pharmaceutical Laboratories

Pharmaceutical company · 63 brands · 58 molecules

Ranked #9 of 29 companies in Vitamin B Complex Plain & With Vitamin C

63 registered products 22 pharmaceutical brands 58 distinct molecules 0 DRAP alerts

Company overview

63
registered products
22
pharmaceutical brands
58
distinct molecules
9
therapeutic classes
0
DRAP alerts

Zanctok Pharmaceutical Laboratories is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 63 product registrations across 58 distinct molecules. Its portfolio is concentrated in Vitamin B Complex Plain & With Vitamin C and Amphenicols. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Vitamin B Complex4 brands
Paracetamol3 brands
Diclofenac3 brands
Diloxanide2 brands
Risperidone2 brands
Hyoscine1 brand

Therapeutic classes

Vitamin B Complex Plain & With Vitamin C · 2Amphenicols · 1Antianemic, Iron & All Combination · 1Potassium Products · 1Digestive Enzymes · 1Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 1Other Urological · 1Sulfonamides And Trimethoprim · 1Antidiarrheals, Intestinal Antiinflammatory/Antiinfective · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official1 products · Rs 753.86 – Rs 753.86
Median across source: Rs 753.86

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for Zanctok

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.